The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

De Marco, G; Helliwell, P; McGonagle, D; Emery, P; Coates, LC; Hensor, EMA; Marzo-Ortega, H

Marzo-Ortega, H (reprint author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Chapel Allerton Hosp, 2nd Floor Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England.

BMC MUSCULOSKELETAL DISORDERS, 2017; 18 ( ):

Abstract

Background: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which impacts significantly on the quality of life and work capacity of affe......

Full Text Link